Hybrid Dump Truck Demonstration Test at South African Mining Site Selected by UNIDO’s Industrial Cooperation Programme

TOKYO, Nov 6, 2025 – (JCN Newswire via SeaPRwire.com) – Hitachi Construction Machinery Co., Ltd. (President and Executive Officer: Masafumi Senzaki) and Hitachi Industrial Products, Ltd. (President and Director: Shintaro Oku) announced that the ‘Hybrid Dump Truck Demonstration Test Project at a South African Mining Site’ being promoted by both companies was selected on November […]

Mitsubishi Power Receives Contract to Upgrade Existing Boiler Equipment at the O Mon 1 Thermal Power Plant in Vietnam

O Mon 1 Thermal Power Plant (Photo: EVNGENCO2) TOKYO, Nov 6, 2025 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Power, a power solutions brand of Mitsubishi Heavy Industries, Ltd. (MHI), has received a contract to support the oil-to-natural gas fuel conversion project at the O Mon 1 Thermal Power Plant in Can Tho in southern […]

NEC and Siemens collaborate to accelerate smart factory innovation

TOKYO, Japan, November 4, 2025 – (JCN Newswire via SeaPRwire.com) – NEC Corporation (NEC; TSE: 6701) has concluded a Technology Partner Program Agreement with Siemens Industry Software Inc. (Siemens) to expand global solutions in the field of 3D robot simulations. Through this agreement, the two companies will further consolidate their strengths, accelerate the deployment of […]

Honda Unveils V3R 900 E-Compressor Prototype Equipped with V3 Engine with Electronically-controlled Compressor at EICMA 2025

Milan, Italy, November 4, 2025 – (JCN Newswire via SeaPRwire.com) – Honda today unveiled the V3R 900 E-Compressor Prototype equipped with a V3 engine with an electronically-controlled compressor, at EICMA 2025 (the Milan Motorcycle Shows.  Press days: November 4-5, Public days: November 6-9) in Milan, Italy. V3R 900 E-Compressor Prototype In order to realize the […]

New CB1000GT, global debut of Honda WN7 electric motorcycle, expansion of Honda E-Clutch line-up and V3R 900 E-Compressor Prototype lead Honda’s EICMA 2025 line-up

Honda WN7 The new CB1000GT combines touring comfort with Fireblade-derived engine performance as a sports tourer,  underpinned by a rich specification list to create a supreme all-round package Making its global debut, the Honda WN7 – Honda’s first EV motorcycle – offers a range of 140km, typical Honda riding dynamics, new design aesthetic and compatibility […]

FWD Group reports strong new business growth

HONG KONG, Nov 3, 2025 – (ACN Newswire via SeaPRwire.com) – FWD Group Holdings Limited (“FWD Group” or “FWD”) today announced strong new business growth for the nine months ended 30 September 2025(1). New business sales were up 37% to US$1.935 billion compared to the same period in 2024 on an annualised premium equivalent (APE) […]

Hitachi High-Tech Announces the SU9600: Next-Generation Ultrahigh-Resolution Scanning Electron Microscope with High Throughput

Ultrahigh-Resolution Scanning Electron Microscope SU9600   TOKYO, October 31, 2025 – (JCN Newswire via SeaPRwire.com) – Hitachi High-Tech Corporation (“Hitachi High-Tech”), has launched the Ultrahigh-Resolution Scanning Electron Microscope SU9600, which allows for highly accurate and precise observation of substances down to the sub-nano level(*1). The SU9600 retains the world-leading high resolution. It also incorporates efficient […]

Sharp to Introduce AQUOS sense10 Smartphone

Japan, October 31, 2025 – (JCN Newswire via SeaPRwire.com) – Sharp Corporation has developed the “AQUOS sense10”, a standard model smartphone, for the global market (*1). It will be released in Japan on November 13, 2025, and will subsequently be available in Taiwan, Indonesia, and Singapore. AQUOS sense10 (from left: Denim Navy, Khaki Green, Pale […]

HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus

HONG KONG, Oct 31, 2025 – (ACN Newswire via SeaPRwire.com) – HighTide Therapeutics, Inc. (2511.HK), a biopharmaceutical company specializing in the development of multifunctional, multi-targeted therapies for chronic metabolic diseases, announced positive 52-week safety and efficacy results from the open-label extension (OLE) phases of two Phase III trials (SYMPHONY-1 and SYMPHONY-2) evaluating HTD1801 in patients with […]